Moderna Operating Expenses 2017-2024 | MRNA

Moderna operating expenses for the twelve months ending September 30, 2024 were $7.774B, a 34.04% decline year-over-year.

  • Moderna annual operating expenses for 2023 were $11.087B, a 12.64% increase from 2022.
  • Moderna annual operating expenses for 2022 were $9.843B, a 90.2% increase from 2021.
  • Moderna annual operating expenses for 2021 were $5.175B, a 230.46% increase from 2020.

Moderna Operating Expenses 2017-2024 | MRNA

  • Moderna annual operating expenses for 2023 were $11.087B, a 12.64% increase from 2022.
  • Moderna annual operating expenses for 2022 were $9.843B, a 90.2% increase from 2021.
  • Moderna annual operating expenses for 2021 were $5.175B, a 230.46% increase from 2020.